wbf943 wbf943
Guest researcher, Guest Researcher
Most downloads
-
318 downloadsPublished
GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release
Research output: Contribution to journal › Journal article › Research › peer-review
-
44 downloadsPublished
Loss of Function Glucose-Dependent Insulinotropic Polypeptide Receptor Variants Are Associated With Alterations in BMI, Bone Strength and Cardiovascular Outcomes
Research output: Contribution to journal › Journal article › Research › peer-review
-
43 downloadsPublished
Effects of endogenous GIP in patients with type 2 diabetes
Research output: Contribution to journal › Journal article › Research › peer-review
-
35 downloadsPublished
Acute concomitant GIP receptor antagonism during GLP-1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity
Research output: Contribution to journal › Journal article › Research › peer-review
-
26 downloadsPublished
Endogenous glucose-dependent insulinotropic polypeptide exerts diverging and tissue specific in obese patients with type 2 diabetes
Research output: Contribution to journal › Conference abstract in journal › Research
ID: 33841862
Most downloads
-
318
downloads
GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
44
downloads
Loss of Function Glucose-Dependent Insulinotropic Polypeptide Receptor Variants Are Associated With Alterations in BMI, Bone Strength and Cardiovascular Outcomes
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
43
downloads
Effects of endogenous GIP in patients with type 2 diabetes
Research output: Contribution to journal › Journal article › Research › peer-review
Published